Stay updated with breaking news from Sciences Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Private Trust Co. NA acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 480 shares of the medical research company’s stock, valued at approximately $45,000. A number of other institutional investors and […]
IFM Investors Pty Ltd lifted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 19.8% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 37,543 shares of the medical research company’s stock after purchasing an additional 6,208 shares during the quarter. IFM Investors […]
EFG Asset Management North America Corp. lowered its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,089 shares of the medical research company’s stock after selling […]
Peregrine Capital Management LLC lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 562,488 shares of the medical research company’s stock after selling 6,009 shares during the quarter. Exact Sciences accounts for […]
Sandler Capital Management purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 67,181 shares of the medical research company’s stock, valued at approximately $4,556,000. A number of other […]